Neko Health has raised $260 million in a Series B funding round to support its research and development efforts and expand into the U.S. and European markets. Co-founded by Daniel Ek, CEO of Spotify, and Hjalmar Nilsonne, the health tech company offers a non-invasive diagnostic scan that utilizes 70 scanners, thermal imaging, and 2D/3D photography to collect approximately 50 million health data points in just 10 minutes. Artificial intelligence analyzes the data and provides users with a comprehensive health report within an hour, helping them identify potential health risks including metabolic syndrome, stroke, and heart disease. Since its launch in Stockholm in early 2023 and London in September 2024, the company has completed more than 10,000 scans, with 80 percent of users prepaying for a follow-up scan the following year.
Lightspeed Venture Partners led the Series B funding round, with participation from General Catalyst and Atomico. As part of the investment, Lightspeed partner Bejul Somaia will join Neko Health’s board. This follows the company’s $65 million Series A funding round in 2023, led by Lakestar. Neko Health plans to use the new funding to expand its locations and further invest in breakthrough technologies aimed at detecting and preventing diseases at an early stage.
